New Horizon Aircraft Ltd

Dustin Shindo filed Amendment No. 3 to his Schedule 13D for New Horizon Aircraft Ltd. (HOVR) on May 27, 2026, reporting 2,656,000 Class A ordinary shares (4.1% of 64.5M shares outstanding), including 120,000 shares underlying private placement warrants at $11.50. His holding percentage declined as HOVR issued 9.25M shares in a May 11 offering and 9.96M share-equivalents in the May 27 offering. Update reflects passive position dilution following two consecutive equity raises; no change in activist intent.

New Horizon Aircraft Ltd. (HOVR) announced the closing of its registered direct offering on May 27, 2026, via a Regulation FD press release (Exhibit 99.1). The 8-K body contains only the Reg FD disclosure header; the specific closing details (proceeds, shares issued) are described more fully in the concurrent 8-K Item 1.01 filing (same date). Routine closing confirmation — offering raised ~$25M as detailed in the Item 1.01 8-K.

New Horizon Aircraft Ltd. (HOVR) entered into Securities Purchase Agreements on May 26, 2026 with institutional investors for a registered direct offering of 5,385,646 Class A ordinary shares and 4,574,514 pre-funded warrants (at $0.001 exercise price) at $2.51 per share, raising gross proceeds of approximately $25 million. Proceeds will fully fund completion of the Cavorite X7 eVTOL prototype and advance it toward testing, certification, and commercial production. Closing expected May 27, 2026. Material dilutive equity raise for a pre-revenue eVTOL company; offering price represented a discount to the recent market price of $3.14.

New Horizon Aircraft Ltd. (HOVR) filed a 424B5 prospectus supplement for a registered direct offering of 5,385,646 Class A ordinary shares plus 4,574,514 pre-funded warrants ($0.001 exercise price) and 298,805 placement agent warrants, at $2.51 per share for ~$25M gross proceeds. The offering price reflects a ~20% discount to the May 22 closing price of $3.14. Titan Partners Group LLC acts as sole placement agent. Dilutive equity issuance to fund eVTOL prototype completion; investors buying via pre-funded warrants to stay under 9.99% ownership threshold.

HOVR filed a 424B5 prospectus supplement to reduce the maximum available under its existing Capital on Demand ATM sales agreement with Jones from $50 million to $28 million total, leaving approximately $6.57 million remaining from the filing date; last price was $3.14 on May 22, 2026. This is an administrative downward revision of shelf availability under an existing at-the-market program rather than a new capital raise.

Nova Vision Acquisition Corp. (HOVR) filed an 8-K under Item 7.01 to satisfy Regulation FD disclosure requirements, ensuring material non-public information is made available to all investors simultaneously. The filing body is primarily XBRL-formatted with limited narrative content. The disclosure likely relates to investor communications, conference presentations, or other forward-looking materials. Exhibits would contain the actual disclosed materials.

Nova Vision Acquisition Corp. (HOVR) filed an 8-K disclosing a material definitive agreement (Item 1.01) alongside a Regulation FD disclosure (Item 7.01). The company entered into a placement or financing agreement with investors or underwriters, and simultaneously made related investor materials publicly available. The transaction likely involves the issuance of equity or debt securities to fund operations or an acquisition. Full agreement terms are included as exhibits.

Nova Vision Acquisition Corp. (HOVR) filed a 424B5 prospectus supplement for a registered direct offering of approximately 9.25 million shares through Titan Partners as placement agent. This final prospectus relates to an existing shelf registration and allows the SPAC or development-stage company to raise capital efficiently. The registered direct structure bypasses traditional underwriting, selling directly to select institutional investors. Proceeds and use of funds are detailed in the prospectus supplement.